c/tirzepatide · created 9 Aug 2023
Dual GIP/GLP-1 agonism. Mounjaro, Zepbound, compounded and research tirzepatide.
what changed for me between month 6 and month 14. Searched first, found three threads that contradict each other, hence the post. Appetite effect for me is flat across…
Putting this to the board: the GIP rule is doing its job and people should stop complaining. On comparing yourself with the trial number. SURMOUNT-1 reported roughly…
help me understand 15mg, I have read the wiki twice. I would rather ask a basic question now than get this wrong quietly for two months. 15mg. Those are measured, not…
Posting this as a discussion rather than a claim: we are measuring GIP at the wrong time and calling it noise. 16kg over 37 weeks, never went past 10mg, and…
Send the vial, get the number. Third-party purity and identity testing, results published to you regardless of what they say.
Test a vialSponsoredEst. 1998. ISO 9001 and cGMP, 1,500+ staff, 200+ patents. There is a fair chance the vial you are about to send for testing started here. Batch-specific COA as standard.
glbiochem.netTrying to get a straight answer on this: can we stop arguing about dual agonist until somebody posts a number. Vials and pens carry the same molecule; what differs is…
Filing this under things worth writing down: QST vs WWB on the same compound, same month — both cleared 99.0%. Figures up front so nobody has to dig: 99.0%. Went 10 to…
proposal — a flair for SURMOUNT posts. Nothing about this affects the ranking maths, before anyone asks. Switching from semaglutide, since three people asked in this…
Asking properly rather than in a comment on somebody else’s thread: 15mg — what am I missing here. Numbers, in the order they matter: 15mg. Appetite effect for me is…
Numbers in the title, numbers in the post. QST vs QYB on the same compound, same month — both cleared 99.0%. To save the first four comments: 99.0%. The step schedule…
Six-word version is the title — week 16 check-in — 5kg down, reflux manageable, one thing confusing me — and the rest is context. The relevant figures are week 16 and…
Posting this as a discussion rather than a claim: my fasting insulin moved and I cannot work out whether Zepbound is why. Vials and pens carry the same molecule; what…
tirzepatide — 22 things I got wrong before I got it right. I have gone back and forth on this for months. The four-week interval in the label is a minimum. Nothing…
the tirzepatide rule is doing its job and people should stop complaining, and it will stay as it is unless somebody makes the case to change it. The four-week interval…
Posting this because the title is the whole finding — 22th independent test on WXT — 99.2% on a claimed 98.5%, and the trend is the interesting part — and a number…
Asking properly rather than in a comment on somebody else’s thread: why does nobody talk about Zepbound. Vials and pens carry the same molecule; what differs is fill…
Vendor-level purity averages over time, built from independent results rather than vendor claims. Transparent methodology, open dataset.
Browse resultsHere it is: 74 weeks, 23kg, and GIP was the hard part. One person, one log, no control group, so read it accordingly. 74 weeks and 23kg. Those are measured, not…
three years of 15mg threads, summarised so you do not have to read them. It is the sort of thing everyone half-believes and nobody writes down. The numbers the title…
Numbers in the title, numbers in the post. split one vial across Medutest and Janoshik — 98.3% and 98.7%. Since the title puts numbers in the shop window: 98.3% and…
26 weeks, 9kg, and dual agonist was the hard part. Full detail below, and I have tried to keep the editorialising out of it. To save the first four comments: 26 weeks…
Numbers in the title, numbers in the post. 21th independent test on WWB — 99.6% on a claimed 99.0%, and the trend is the interesting part. To save the first four…
Posting this as a discussion rather than a claim: the GIP advice in here is 2 years out of date. To save the first four comments: 2 years. The step schedule question,…
the Zepbound rule is doing its job and people should stop complaining — with the counter-argument included, because I find it fairly persuasive. Weekly dosing again,…
tirzepatide — what am I missing here. If this has been answered properly somewhere, link me and I will delete. Went 10 to 12.5 on the calendar and had the worst…
split one vial across Janoshik and Medutest — 99.2% and 96.2%. One vial, one service, one member paying, which is the only kind of result this board should treat as…
Trying to get a straight answer on this: how much of what we believe about GIP actually comes from SURMOUNT threads. On comparing yourself with the trial number.…
Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.
Independent testing plus vendor-level trend data. Community-funded, unaffiliated.
peptidemeter.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference